Professor after ESSM: "The interest in Dicot Pharma's work continues to grow"
Uppsala, Sweden, February 26, 2025. Dicot Pharma's potency drug candidate attracted a lot of attention during this weekend's edition of Europe's largest conference in sexual medicine.
The pharmaceutical company Dicot Pharma was invited to present its clinical studies at ESSM, the leading European conference in sexual medicine, organized by the European Society for Sexual Medicine. The recurring conference, which this year took place on February 20-22 in Vienna, brings together the foremost experts in the field and serves as a central platform for the latest research findings and innovations.
Dicot Pharma was represented by its CSO Charlotta Gauffin and Professor François Giuliano, a urologist and specialist in male sexual health and former President of ESSM. Professor Giuliano gave a podium presentation of the results from the company's phase 1 clinical trial and the design of the ongoing phase 2a trial, in which he is involved as a medical expert.
- I can see that the awareness of and interest in Dicot Pharma’s work continues to grow in the community of sexual medicine. During the conference, several leading experts within the field have showed interest, asked questions, and expressed their enthusiasm," comments Professor Giuliano.